Thoracentesis vs Paracentesis: When to Use Each

Thoracentesis and paracentesis are both needle-based procedures that drain abnormal fluid buildup from a body cavity, but they target different locations: thoracentesis removes fluid from the pleural space surrounding the lungs, while paracentesis removes fluid from the peritoneal cavity in the abdomen. The distinction sounds straightforward, and anatomically it is. But the two procedures differ in meaningful ways when it comes to why they are performed, how the drained fluid is analyzed, what complications to watch for, and what additional treatments may be needed afterward.

Where Each Procedure Happens and Why

The pleural space is the thin gap between the two membranes lining your lungs and chest wall. Normally it holds just a few teaspoons of lubricating fluid. When disease causes excess fluid to accumulate there, the condition is called a pleural effusion, and it can compress the lung enough to cause shortness of breath, chest pain, and a persistent cough. Thoracentesis involves inserting a needle through the back of the chest wall, usually between the ribs, to withdraw that fluid.

The peritoneal cavity is the space inside the abdomen that houses the intestines, liver, and other organs. Abnormal fluid accumulation here is called ascites, most commonly caused by liver cirrhosis and the portal hypertension that goes with it. Ascites can also result from cancer, heart failure, or kidney disease. Paracentesis involves inserting a needle through the abdominal wall, typically in the lower left quadrant, to drain the fluid.

Both procedures serve two broad purposes. A diagnostic tap removes a small sample of fluid for laboratory testing, helping clinicians figure out the underlying cause. A therapeutic tap removes a large volume of fluid to relieve symptoms like breathing difficulty or abdominal distension. Malignant fluid collections in both the chest and abdomen can be managed with either intermittent drainage or placement of longer-term catheters.¹

The Role of Ultrasound Guidance

One of the biggest practical advances for both procedures has been the routine use of bedside ultrasound. Ultrasound lets the clinician see exactly where the fluid is sitting, how deep the pocket is, and where nearby organs or vessels lie. This matters because both procedures involve putting a needle into a body cavity near vital structures.

A large study using national hospitalization data found that ultrasound guidance reduced the risk of pneumothorax after thoracentesis by about 19% and cut the risk of bleeding complications after paracentesis by roughly 68%.² The cost savings were substantial too: a pneumothorax added nearly $2,800 to a hospitalization and extended the stay by a day and a half, while a bleeding complication from paracentesis added over $19,000 and more than four extra days.³ Modern clinical guidance now considers point-of-care ultrasound standard practice for both procedures, having further reduced complication rates beyond what landmark studies already demonstrated.⁴

Different Fluid, Different Lab Tests

Once the fluid is out, clinicians analyze it to determine what caused the buildup. This is where thoracentesis and paracentesis diverge most sharply, because the two body cavities use different classification systems.

Pleural Fluid and Light’s Criteria

For pleural effusions, the central question is whether the fluid is a transudate or an exudate. Transudative effusions typically result from systemic conditions like heart failure or cirrhosis that change the pressure balance across the pleural membranes. Exudative effusions point to a local problem affecting the pleura itself, such as infection, cancer, or inflammation. The distinction matters because it steers the entire diagnostic workup in different directions.

The standard tool for making this call is Light’s criteria, a set of lab thresholds comparing protein and enzyme levels in the fluid to those in the blood. Light’s criteria have been studied repeatedly and remain the benchmark: one study found their accuracy for identifying exudates was about 95%,⁵ and a separate analysis confirmed a sensitivity of 99% and accuracy of 96%, outperforming newer proposed alternatives.⁶ No competing system has managed to displace them in decades of attempts.

One known quirk: Light’s criteria occasionally mislabel a transudative effusion as exudative, especially in patients on diuretics whose fluid protein levels have been artificially concentrated. Clinicians generally know to look for this and use additional markers like serum-to-pleural-fluid albumin gradient to catch the error.

Ascitic Fluid and the SAAG

For ascitic fluid, the transudate-versus-exudate framework was largely abandoned in favor of the serum-ascites albumin gradient, or SAAG. This test simply subtracts the albumin concentration in the ascitic fluid from the albumin concentration in the blood. A gradient of 1.1 g/dL or higher strongly suggests that portal hypertension is driving the fluid accumulation, as you would expect in cirrhosis. A gradient below 1.1 points toward other causes like cancer spreading to the peritoneum, tuberculosis, or pancreatic disease.

The SAAG works well for its intended purpose: in a large pediatric study, it correctly differentiated portal hypertension from non-portal-hypertension causes of ascites in about 89% of cases, with sensitivity around 97% and diagnostic accuracy near 96%.⁷ That said, its performance is not perfectly consistent everywhere. A study in Mexican patients found the SAAG correctly classified only 67% of cases, with notably lower sensitivity, raising questions about whether the standard 1.1 cutoff works equally well across all populations.⁸ Most clinicians still rely on SAAG as a first-line tool, but these findings suggest it deserves some healthy skepticism when the clinical picture does not match the number.

Beyond classifying the cause, ascitic fluid is routinely checked for infection. Spontaneous bacterial peritonitis is a common and dangerous complication in cirrhosis patients with ascites, diagnosed when the fluid’s white-cell count exceeds a specific threshold. An analogous condition exists on the pleural side: spontaneous bacterial empyema follows similar diagnostic criteria and arises in cirrhosis patients who develop hepatic hydrothorax, where ascitic fluid migrates through tiny diaphragmatic defects into the pleural space.⁹¹⁰

Complications Specific to Each Procedure

Both procedures are considered safe, but the risks are not identical because of the different anatomy involved.

The signature complication of thoracentesis is pneumothorax, where air leaks into the pleural space when the needle punctures the lung or allows air entry. A meta-analysis pooling data from over 6,600 thoracenteses found an overall pneumothorax rate of about 6%, with roughly a third of those cases requiring a chest tube to fix.¹¹ The risk was higher with therapeutic taps that remove large volumes and lower when ultrasound was used.¹² Experienced operators had lower rates than less experienced ones, though the difference was not always statistically significant within individual studies.

Paracentesis does not carry pneumothorax risk, but bleeding is the main concern. A systematic review cataloged the types of hemorrhagic complications: abdominal wall hematomas accounted for about 52% of cases, bleeding into the peritoneal cavity made up 41%, and pseudoaneurysms at the puncture site accounted for the remaining 7%.¹³ These sound alarming, but the absolute rate of clinically significant bleeding is quite low, even in patients whose blood clotting is impaired from liver disease.

Bleeding Risk and the Coagulopathy Question

This is an area where the conventional wisdom has shifted. Many patients who need thoracentesis or paracentesis have liver disease, and liver disease often leads to abnormal clotting tests. For years, doctors routinely gave fresh frozen plasma or platelet transfusions before performing either procedure in these patients, hoping to prevent bleeding. The evidence now suggests this was largely unnecessary.

A foundational study found no increased bleeding in patients with mild-to-moderate coagulopathy, defined as clotting times up to twice the normal value or platelet counts between 50,000 and 99,000 per microliter. The overall rate of bleeding complications requiring a blood transfusion was just 0.2%, leading the authors to conclude that prophylactic plasma or platelet transfusions are not needed for these patients.¹⁴

More recent guidance has pushed even further, with expert consensus from hepatology, interventional radiology, and critical care concluding that major hemorrhagic complications occur in fewer than 1% of cases. Safe practice extends down to platelet counts in the 20,000 to 50,000 range without transfusion in stable patients. An elevated INR from cirrhosis does not reflect true procedural bleeding risk because the standard clotting test was designed for patients on warfarin, not for the rebalanced hemostatic state of chronic liver disease. Aspirin, blood thinners, and antiplatelet drugs do not universally require interruption for urgent drainage, because the procedural bleeding risk is very low while the risk of a clot from stopping those medications may be high.¹⁵ This represents a genuine sea change from the cautious approach that dominated practice even a decade ago.

Therapeutic Drainage and Volume Considerations

When the goal is symptom relief rather than diagnosis, the volumes removed can be large, and the two procedures handle this differently.

In thoracentesis, clinicians typically limit drainage to about 1 to 1.5 liters at a time. Removing too much fluid too quickly risks re-expansion pulmonary edema, a condition where the lung, having been compressed by fluid for a prolonged period, rapidly reinflates and develops swelling. If a patient develops chest tightness, coughing, or discomfort during the procedure, drainage is usually stopped.

Paracentesis can be more aggressive. Large-volume paracentesis often removes five liters or more in a single session, and in some patients with tense ascites, eight or more liters may come off. But draining this much abdominal fluid creates a unique problem: paracentesis-induced circulatory dysfunction, or PICD. When a large volume of ascites is removed, the pressure dynamics in the abdomen shift, causing blood to pool in the splanchnic circulation. This triggers a cascade of hormonal responses that can worsen kidney function, lower blood sodium, and increase the risk of complications and death.

The standard countermeasure is albumin infusion. A meta-analysis of randomized trials found that albumin significantly reduces the incidence of PICD compared both to no treatment and to alternative volume expanders like dextran or gelatin.¹⁶ The typical dosing studied is 6 to 8 grams of albumin per liter of fluid removed.¹⁷ Interestingly, PICD can occur even with modest-volume taps. A randomized trial in patients with acute-on-chronic liver failure found that PICD developed in 70% of patients who did not receive albumin during paracenteses of fewer than five liters, compared to 30% of those who did. The no-albumin group also had significantly higher rates of kidney injury, hepatic encephalopathy, and in-hospital death.¹⁸

Thoracentesis does not require albumin replacement. The volumes involved are smaller, and the pleural space does not have the same hemodynamic relationship with the circulatory system that the peritoneal cavity does. This is one of the starkest practical differences between the two procedures.

When Repeated Procedures Become Unsustainable

Some patients need fluid drained again and again. Malignant pleural effusions and refractory ascites from end-stage liver disease or cancer are the classic scenarios. Coming to the hospital every week or two for a needle procedure is burdensome, and each tap carries its own small risk of complications.

The alternative for these patients is an indwelling tunneled catheter. Pleural catheters (often called indwelling pleural catheters) and peritoneal catheters allow patients or their caregivers to drain fluid at home on a schedule. Data from a Danish tertiary center found that these catheters are safe and effective, with low infection rates, minimal hospital visits, and a substantial proportion of patients able to continue living independently.¹⁹ In the pleural space, an added benefit is that the catheter can trigger pleurodesis, where the two pleural membranes scar together and prevent further fluid accumulation. This spontaneous pleurodesis occurs in a meaningful fraction of patients, sometimes allowing the catheter to be removed entirely.

Who Performs These Procedures

The landscape of who actually performs thoracentesis and paracentesis has been changing. Traditionally, both procedures were done at the bedside by internists, pulmonologists, or gastroenterologists. More recently, interventional radiologists have taken on a growing share of the volume. Between 2014 and 2022, the number of paracenteses performed by radiologists in a large U.S. dataset jumped from roughly 3,100 per year to nearly 16,900, while thoracenteses rose from about 1,900 to over 9,700.²⁰ The average number of procedures per radiologist per year also climbed substantially, suggesting these are becoming core activities for radiology practices rather than occasional requests.

This shift reflects the broader push toward image-guided procedures, but it has also raised questions about training for other specialties. Operator experience matters: pneumothorax rates in thoracentesis were lower with experienced practitioners, and simulation-based training programs have shown measurable improvements in patient outcomes.²¹ As more procedures migrate to radiology suites, ensuring that bedside clinicians retain competence for urgent or after-hours cases remains an ongoing tension in medical training.

Hepatic Hydrothorax and the Overlap Between Cavities

There is one condition that blurs the line between these two procedures in an interesting way. Hepatic hydrothorax occurs when ascitic fluid from the abdomen migrates into the pleural space through tiny defects in the diaphragm. The patient has a pleural effusion, but the underlying cause is the same portal hypertension driving their ascites. This means the treatment often involves managing the abdominal disease rather than focusing solely on the chest. Diuretics, sodium restriction, and TIPS (a procedure to reduce portal pressure) may help more than repeatedly draining the chest.

Hepatic hydrothorax also explains the existence of spontaneous bacterial empyema, the pleural counterpart of spontaneous bacterial peritonitis. Because the fluid originally comes from the peritoneal cavity, the same gut bacteria that cause peritonitis can seed the pleural space. The diagnostic criteria are analogous: an elevated white-cell count in the pleural fluid with either a positive culture or a very high cell count even with negative cultures, plus exclusion of a lung infection as the source.²² For a patient with cirrhosis who develops a new pleural effusion, clinicians need to consider this possibility alongside the more common causes of fluid in the chest.